GO:0032966 negative regulation of collagen biosynthetic process: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032966 describes any process that stops, prevents, or reduces the frequency, rate or extent of collagen biosynthesis, a key control point in extracellular matrix (ECM) homeostasis.
• Collagen biosynthesis is regulated at multiple levels, including transcription, mRNA stability, translation, post-translational modification, and intracellular degradation.
• SEL1L is a newly identified intracellular rheostat that controls collagen turnover and negatively regulates collagen biosynthesis through ER-associated degradation.
• Signaling pathways such as TGF-beta, Akt, store-operated Ca2+ entry, and PPARalpha-SIRT1-AMPK modulate collagen expression and can suppress collagen production.
• Dysregulation of negative regulation of collagen biosynthesis contributes to fibrosis, cancer, vascular calcification, and connective tissue disorders.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of genes controlling collagen biosynthesis.
Description
Collagen is the most abundant protein in mammals and provides structural integrity to connective tissues, but its overproduction or aberrant deposition underlies numerous pathologies, including fibrosis, cancer, and vascular disease. The Gene Ontology term GO:0032966, negative regulation of collagen biosynthetic process, captures the cellular mechanisms that restrain collagen synthesis and accumulation. Understanding these mechanisms is essential for identifying therapeutic targets that can halt or reverse excessive collagen deposition. Collagen biosynthesis is a complex, multi-step process that begins with transcription of collagen genes and proceeds through mRNA processing, translation, post-translational hydroxylation and glycosylation, triple-helix formation, secretion, and extracellular fibril assembly. Negative regulation can occur at any of these steps, either by reducing the rate of synthesis or by enhancing the degradation of collagen and its precursors. Recent genome-wide screens have uncovered conserved regulators such as SEL1L that actively promote collagen turnover, highlighting the importance of intracellular quality-control pathways in limiting collagen accumulation. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0032966, covering its definition, biological significance, key genes, disease relevance, and experimental approaches for studying it.
negative regulation of collagen biosynthetic process At A Glance
| GO ID | GO:0032966 |
|---|---|
| GO term | negative regulation of collagen biosynthetic process |
| Ontology | biological_process |
| Synonym | negative regulation of collagen anabolism; negative regulation of collagen biosynthesis; negative regulation of collagen formation; negative regulation of collagen synthesis |
| Major function | Suppression of collagen production at transcriptional, post-transcriptional, translational, or post-translational levels |
| Related biological process | Collagen biosynthetic process (GO:0032964); regulation of collagen biosynthetic process (GO:0032965) |
| Cellular context | Extracellular matrix homeostasis, endoplasmic reticulum quality control, connective tissue remodeling |
| Disease relevance | Fibrosis, cancer, vascular calcification, connective tissue disorders |
What Is GO:0032966?
GO:0032966, negative regulation of collagen biosynthetic process, is defined as any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, a group of fibrous proteins with very high tensile strength that form the main component of connective tissue in animals. In practice, this term encompasses molecular events that suppress collagen gene expression, impair collagen mRNA translation, accelerate collagen precursor degradation, or otherwise limit the production of mature collagen molecules.
Why Is negative regulation of collagen biosynthetic process Important in Cell Biology?
Negative regulation of collagen biosynthesis is critical for maintaining tissue architecture and preventing pathological ECM accumulation. Excessive collagen deposition is a hallmark of fibrosis in organs such as lung, liver, kidney, and heart, and contributes to cancer progression and vascular calcification. Conversely, insufficient collagen production leads to connective tissue fragility. Understanding the molecular brakes on collagen synthesis provides opportunities for therapeutic intervention in fibrotic and malignant diseases.
• Prevents excessive ECM deposition and fibrosis in multiple organs.
• Controls tissue remodeling during development and wound healing.
• Dysregulation is implicated in cancer-associated desmoplasia and metastasis.
• Modulates vascular calcification in diabetes and cardiovascular disease.
• Influences connective tissue disorders such as conjunctivochalasis.
• Provides targets for anti-fibrotic drug discovery.
• Involves ER-associated degradation (ERAD) and autophagy pathways.
• Crosstalk with TGF-beta, Akt, and calcium signaling pathways.
• Relevant to adipocyte biology and metabolic regulation.
• Enables CRISPR-based functional genomics of collagen regulation.
What Happens During negative regulation of collagen biosynthetic process?
Transcriptional suppression of collagen genes
In simple terms: The cell reduces the first step of collagen production by making less collagen mRNA.
Negative regulation of collagen biosynthesis can begin with reduced transcription of collagen genes such as COL1A1, COL1A2, and COL4A1. Signaling pathways including TGF-beta, Akt, and store-operated Ca2+ entry can suppress collagen promoter activity or downstream transcriptional programs. For example, store-operated Ca2+ entry negatively regulates Smad1 pathway and collagen IV expression in glomerular mesangial cells. Similarly, Akt signaling modulates the expression of collagens and MMPs in conjunctivochalasis.
Post-transcriptional and translational control
In simple terms: Even if collagen mRNA is made, the cell can stop it from being translated into protein.
Collagen mRNA stability and translation are regulated by RNA-binding proteins and microRNAs. Although specific mechanisms vary by cell type, the net effect is reduced synthesis of collagen polypeptides. Genome-wide screens have identified factors that control collagen turnover at the protein level, indirectly affecting the pool of collagen available for assembly.
Intracellular degradation of collagen precursors
In simple terms: The cell can destroy collagen molecules before they are secreted.
SEL1L, an ER-resident protein, acts as an intracellular rheostat controlling collagen turnover by promoting ER-associated degradation of collagen precursors. This represents a major negative regulatory mechanism that prevents accumulation of misfolded or excess collagen within the secretory pathway. Autophagy also contributes to collagen degradation, as shown by silibinin-induced autophagy mediated by PPARalpha-SIRT1-AMPK pathway in preadipocytes.
Extracellular matrix remodeling and feedback
In simple terms: Outside the cell, enzymes can break down collagen, reducing its overall amount.
Matrix metalloproteinases (MMPs) degrade extracellular collagen, and their expression is often coordinated with negative regulation of collagen synthesis. TGF-beta1-mediated downregulation of L1CAM in pancreatic ductal adenocarcinoma drives upregulation of collagen 17A1 and MMP2, illustrating the interplay between collagen production and degradation. Acetylation-ubiquitination crosstalk of DJ-1 mediates microcalcification via collagen-matrix vesicles interaction, linking collagen regulation to vascular pathology.
Key Genes Involved in GO:0032966 negative regulation of collagen biosynthetic process
The following genes and proteins have been experimentally implicated in the negative regulation of collagen biosynthetic process or in related regulatory pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SEL1L | ER-resident protein promoting collagen degradation via ERAD | Genome-wide screens identify SEL1L as an intracellular rheostat controlling collagen turnover |
| COL1A1 | Major fibrillar collagen; its synthesis is negatively regulated | Transcriptional and post-transcriptional control of collagen I |
| COL1A2 | Major fibrillar collagen; its synthesis is negatively regulated | Coordinate regulation with COL1A1 |
| COL4A1 | Basement membrane collagen; negatively regulated by Ca2+ entry | Store-operated Ca2+ entry suppresses collagen IV expression |
| COL17A1 | Transmembrane collagen; upregulated in cancer | TGF-beta1-mediated L1CAM downregulation drives COL17A1 upregulation |
| SMAD1 | Transcription factor in TGF-beta/BMP signaling | Negatively regulated by store-operated Ca2+ entry, affecting collagen IV |
| AKT | Serine/threonine kinase modulating collagen and MMP expression | Akt regulates collagens and MMPs in conjunctivochalasis |
| PPARalpha | Nuclear receptor involved in lipid metabolism and autophagy | Silibinin-induced autophagy via PPARalpha-SIRT1-AMPK regulates collagen I |
| SIRT1 | NAD+-dependent deacetylase | Part of PPARalpha-SIRT1-AMPK pathway regulating collagen |
| AMPK | Energy sensor kinase | Mediates silibinin-induced autophagy and collagen regulation |
| DJ-1 | Oxidative stress sensor; acetylation-ubiquitination crosstalk | Mediates microcalcification via collagen-matrix vesicles |
| MMP2 | Matrix metalloproteinase degrading collagen | Upregulated with COL17A1 in pancreatic cancer |
| L1CAM | Cell adhesion molecule | TGF-beta1 downregulates L1CAM, leading to collagen changes |
| TGF-beta1 | Cytokine regulating collagen synthesis | Downregulates L1CAM and modulates collagen in cancer |
| ITGA2B | Integrin alpha-IIb | Negative regulation of activated alpha-2 integrins during thrombopoiesis |
| COL4A | Basement membrane collagen network | Negatively regulated by Ca2+ entry in mesangial cells |
How Is negative regulation of collagen biosynthetic process Regulated?
Negative regulation of collagen biosynthesis is controlled by multiple signaling pathways. TGF-beta1 can either promote or suppress collagen depending on context; in pancreatic ductal adenocarcinoma, TGF-beta1-mediated downregulation of L1CAM drives upregulation of COL17A1 and MMP2. Store-operated Ca2+ entry negatively regulates Smad1 pathway and collagen IV expression in glomerular mesangial cells. The PPARalpha-SIRT1-AMPK pathway mediates silibinin-induced autophagy, which reduces type I collagen-enhanced migration in preadipocytes. Akt signaling modulates collagen and MMP expression in conjunctivochalasis. At the protein level, SEL1L acts as an intracellular rheostat controlling collagen turnover through ER-associated degradation. These pathways collectively fine-tune collagen production to meet physiological demands while preventing excessive accumulation.
negative regulation of collagen biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SEL1L | Fibrosis, collagen turnover disorders | Sel1l knockout or knockdown in fibroblasts; ERAD reporter assays |
| COL17A1 | Pancreatic ductal adenocarcinoma metastasis | CRISPR knockout of COL17A1 in PDAC cell lines; invasion assays |
| DJ-1 | Diabetic vascular calcification | DJ-1 point mutation or knockout in vascular smooth muscle cells; calcification assays |
| SMAD1 | Glomerular fibrosis, collagen IV regulation | Smad1 knockout in mesangial cells; Ca2+ entry modulation |
| PPARalpha | Metabolic disorders, collagen I regulation | Pparalpha knockout in 3T3-L1 preadipocytes; autophagy assays |
Fibrosis and ECM remodeling
Loss of negative regulation of collagen biosynthesis leads to excessive collagen deposition, a hallmark of fibrosis in lung, liver, kidney, and heart. SEL1L-mediated collagen turnover is a key protective mechanism; its dysfunction may contribute to fibrotic diseases. Store-operated Ca2+ entry negatively regulates collagen IV in mesangial cells, and its impairment could exacerbate glomerular fibrosis.
Cancer progression and metastasis
In pancreatic ductal adenocarcinoma, TGF-beta1-mediated downregulation of L1CAM drives upregulation of collagen 17A1 and MMP2, facilitating tumor invasiveness and metastasis. This illustrates how disruption of negative regulatory circuits can promote a pro-tumorigenic ECM. Akt signaling modulates collagens and MMPs in conjunctivochalasis, a condition with altered ECM.
Vascular calcification and metabolic disease
Acetylation-ubiquitination crosstalk of DJ-1 mediates microcalcification formation in diabetic plaques via collagen-matrix vesicles interaction, linking collagen regulation to vascular pathology. Silibinin-induced autophagy via PPARalpha-SIRT1-AMPK regulates type I collagen-enhanced migration in preadipocytes, relevant to obesity and metabolic disorders.
From negative regulation of collagen biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SEL1L negatively regulate collagen biosynthesis? | SEL1L knockout in fibroblasts; collagen turnover assays |
| How does Akt modulate collagen and MMP expression? | Akt point mutation or knockout in conjunctivochalasis cells |
| Does PPARalpha-SIRT1-AMPK mediate collagen regulation? | Knockout of PPARalpha, SIRT1, or AMPK in preadipocytes |
| What is the role of COL17A1 in cancer invasion? | COL17A1 knockout or overexpression in PDAC cells |
| How does DJ-1 acetylation affect collagen-matrix vesicles? | DJ-1 knock-in of acetylation mimics in vascular cells |
| Does store-operated Ca2+ entry regulate collagen IV? | SMAD1 knockout or Ca2+ channel knockout in mesangial cells |
How to Study the negative regulation of collagen biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Genome-wide CRISPR screen | Genes whose loss alters collagen levels | Identify negative regulators like SEL1L |
| RNA-seq | Collagen mRNA expression | Transcriptional regulation by Akt, TGF-beta |
| Proteomics | Collagen protein abundance and modifications | Post-translational regulation, ERAD |
| Immunofluorescence | Collagen fibril localization and matrix vesicles | Vascular calcification, fibrosis |
| Hydroxyproline assay | Total collagen content | Quantify collagen synthesis in cell lysates |
| Autophagy flux assay | Autophagic degradation of collagen | PPARalpha-SIRT1-AMPK pathway |
| Luciferase reporter | Collagen promoter activity | Transcriptional suppression by Ca2+ entry |
| Invasion/migration assay | Cell migration in collagen-rich matrix | Cancer metastasis, preadipocyte biology |
Genome-wide CRISPR screens
Genome-wide screens identify SEL1L as an intracellular rheostat controlling collagen turnover, demonstrating the power of CRISPR-based functional genomics to uncover negative regulators of collagen biosynthesis. Such screens can be adapted to other cell types to find novel regulators.
Transcriptomic and proteomic profiling
RNA-seq and proteomics can quantify collagen mRNA and protein levels following genetic perturbations. For example, Akt regulation of collagens and MMPs in conjunctivochalasis was studied using expression profiling. SEL1L-dependent changes in collagen turnover were assessed by protein stability assays.
Imaging and histological analysis
Immunofluorescence and electron microscopy visualize collagen fibrils and matrix vesicles. DJ-1-mediated microcalcification via collagen-matrix vesicles interaction was studied using imaging techniques. Collagen I-enhanced migration in preadipocytes was monitored by live-cell imaging.
Functional assays for collagen synthesis and degradation
Collagen biosynthesis can be measured by radioactive proline incorporation, hydroxyproline assays, or luciferase reporters driven by collagen promoters. Autophagy flux assays and ERAD activity assays are used to study degradation pathways.
How CRISPR Can Be Used to Study GO:0032966 negative regulation of collagen biosynthetic process
Knockout
CRISPR knockout of candidate negative regulators such as SEL1L, SMAD1, or PPARalpha can confirm their role in suppressing collagen biosynthesis. For example, SEL1L knockout increases collagen accumulation, validating its function as an intracellular rheostat. SMAD1 knockout alters collagen IV expression in mesangial cells.
Point Mutation
Point mutations can dissect specific domains or phosphorylation sites. For instance, DJ-1 acetylation-ubiquitination crosstalk can be studied by introducing acetylation-mimetic or -deficient point mutations to assess effects on collagen-matrix vesicles and microcalcification. Akt point mutants can reveal residues critical for collagen regulation.
Knock-in
Knock-in of tagged collagen genes (e.g., COL1A1-GFP) allows real-time tracking of collagen synthesis and secretion. Knock-in of disease-associated mutations in COL17A1 or COL4A1 can model connective tissue disorders and cancer. SEL1L knock-in with epitope tags facilitates ERAD studies.
Overexpression
Overexpression of negative regulators such as SEL1L or PPARalpha can reduce collagen levels and mitigate fibrosis in cell models. Conversely, overexpression of collagen genes or their activators can model excessive collagen deposition. CRISPR activation (CRISPRa) enables targeted overexpression without transgenes.
How EDITGENE Supports negative regulation of collagen biosynthetic process Research
Researchers studying negative regulation of collagen biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in suppressing collagen production or whether its effect is secondary. Precise genetic models are essential to establish causality and to dissect the molecular mechanisms by which genes such as SEL1L, SMAD1, or PPARalpha control collagen biosynthesis.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of collagen biosynthetic process research.
Frequently Asked Questions About negative regulation of collagen biosynthetic process
What is GO:0032966?
GO:0032966 is the Gene Ontology term for negative regulation of collagen biosynthetic process, describing any process that stops, prevents, or reduces the frequency, rate or extent of collagen formation.
What genes are involved in negative regulation of collagen biosynthetic process?
Key genes include SEL1L, SMAD1, PPARalpha, SIRT1, AMPK, Akt, and DJ-1, which modulate collagen synthesis or degradation through various pathways.
How does SEL1L regulate collagen biosynthesis?
SEL1L acts as an intracellular rheostat that promotes ER-associated degradation of collagen precursors, thereby reducing collagen accumulation.
What diseases are associated with defective negative regulation of collagen biosynthesis?
Fibrosis, cancer metastasis, vascular calcification, and connective tissue disorders are linked to impaired suppression of collagen production.
How can CRISPR be used to study negative regulation of collagen biosynthesis?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of candidate genes to test their effects on collagen levels and related phenotypes.
What signaling pathways negatively regulate collagen synthesis?
TGF-beta, Akt, store-operated Ca2+ entry, and PPARalpha-SIRT1-AMPK pathways have been shown to suppress collagen expression or promote its degradation.
What is the role of autophagy in collagen regulation?
Autophagy can degrade collagen and its precursors; silibinin-induced autophagy via PPARalpha-SIRT1-AMPK reduces type I collagen-enhanced migration in preadipocytes.
How does store-operated calcium entry affect collagen IV?
Store-operated Ca2+ entry negatively regulates Smad1 pathway and collagen IV expression in glomerular mesangial cells.
What experimental models are used to study collagen biosynthesis regulation?
Common models include CRISPR knockout cell lines, overexpression systems, genome-wide screens, and biochemical assays for collagen synthesis and degradation.
Why is negative regulation of collagen biosynthesis important for cancer?
In pancreatic cancer, loss of negative regulation leads to upregulation of collagen 17A1 and MMP2, promoting tumor invasion and metastasis.
Conclusion
GO:0032966, negative regulation of collagen biosynthetic process, is a critical biological process that restrains collagen production at multiple levels, from transcription to protein degradation. Its dysregulation contributes to fibrosis, cancer, and vascular disease, making it a rich area for therapeutic targeting. Advances in CRISPR-based functional genomics have already identified key regulators such as SEL1L, and further studies will likely uncover additional mechanisms. Researchers can leverage EDITGENE's comprehensive CRISPR services, including knockout, point mutation, knock-in, overexpression, and library screening, to dissect the genes and pathways controlling collagen biosynthesis and to develop novel interventions for collagen-related diseases.
References
- 1. Podolsky MJ et al.. 2024. Genome-wide screens identify SEL1L as an intracellular rheostat controlling collagen turnover.. Nat Commun 15(1):1531 PMID: 38378719
- 2. Adams SL. 1989. Collagen gene expression.. Am J Respir Cell Mol Biol 1(3):161-8 PMID: 2696511
- 3. Zou Z et al.. 2009. Negative regulation of activated alpha-2 integrins during thrombopoiesis.. Blood 113(25):6428-39 PMID: 19258597
- 4. Ma K et al.. 2023. Mechanism of Akt regulation of the expression of collagens and MMPs in conjunctivochalasis.. Exp Eye Res 226:109313 PMID: 36403850
- 5. Liu X et al.. 2019. Silibinin-induced autophagy mediated by PPARα-sirt1-AMPK pathway participated in the regulation of type I collagen-enhanced migration in murine 3T3-L1 preadipocytes.. Mol Cell Biochem 450(1-2):1-23 PMID: 29916120
- 6. Cave DD et al.. 2025. TGF-β1-mediated downregulation of L1CAM in pancreatic ductal adenocarcinoma drives upregulation of collagen 17A1 and MMP2, facilitating tumor invasiveness and metastasis.. Cell Death Dis 16(1):592 PMID: 40770187
- 7. Sun Z et al.. 2025. Acetylation-ubiquitination crosstalk of DJ-1 mediates microcalcification formation in diabetic plaques via collagen-matrix vesicles interaction.. Cardiovasc Res 121(2):296-310 PMID: 39786474
- 8. Wu P et al.. 2017. Negative regulation of Smad1 pathway and collagen IV expression by store-operated Ca(2+) entry in glomerular mesangial cells.. Am J Physiol Renal Physiol 312(6):F1090-F1100 PMID: 28298362
